Skip to main content

OSA

1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Prevail Therapeutics
1 program
1
OrforglipronPhase 3
ResMed
ResMedSAN DIEGO, CA
2 programs
CPAPN/A1 trial
Nasal maskN/A1 trial
Active Trials
NCT05435794Recruiting400Est. Oct 2026
NCT01690923Completed20Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ResMedCPAP
ResMedNasal mask

Clinical Trials (2)

Total enrollment: 420 patients across 2 trials

Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients

Start: Jul 2022Est. completion: Oct 2026400 patients
N/ARecruiting

Nasal Pillows vs. Nasal Masks at High CPAP Pressure

Start: Aug 2011Est. completion: Dec 201220 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 420 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.